MIF and neoplasm: Secreted cytokines (MIF/CSF1) mainly target C1QC+TAMs to impede the antitumor immune effects of TAMs rather than those of SPP1+TAMs, suggesting that anti-CSF or MIF treatments may be insufficient to deplete macrophage subgroups with tumor growth-promoting potential [44].